Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for t...
AstraZeneca will gain full rights for roxadustat in China where it is approved t...
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants t...
X4 has entered an exclusive agreement with taiba rare for distributing and comme...
In this review, GlobalData considers the products both approved and priced in 20...
The World Health Organization (WHO) said it will conduct another mass vaccinatio...
ImmunityBio has gained the FDA authorisation for an EAP to supply an alternative...
The FDA, NIH and CDC has cut 5,200 probationary staff in a job cull across the H...
FDA has granted priority review for Boehringer Ingelheim’s zongertinib NDA for t...
A team of scientists has developed a new AI-based foundation model that can give...
CSL Behring KK has gained approval from Japan's MHLW to manufacture and market s...
As Sanofi and Regeneron await the FDA decision, a legal dispute between the part...
HMRI has signed a memorandum of understanding (MoU) with Novartis Australia for ...
The US FDA has granted fast track designation to Rznomics' RZ-001 for the treatm...
Ono’s therapy Romvimza is administered twice-weekly compared to Daiichi Sankyo’s...
Oncology studies present unique challenges when it comes to participant treatmen...
